Universal Ibogaine Inc Cash Flow-to-Debt Ratio
Universal Ibogaine Inc cash flow-to-debt ratio. Universal Ibogaine Inc (IBO) has a Cash Flow-to-Debt Ratio of -0.03x as of April 2025, meaning its operating cash flow of CA$-110.36K could theoretically repay 0% of its total liabilities (CA$3.73 Million) in one year. See financial flexibility index of Universal Ibogaine Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Universal Ibogaine Inc (2018–2024)
Cash flow-to-debt ratio of Universal Ibogaine Inc from 2018 to 2024. Historical debt coverage capacity for Universal Ibogaine Inc across 7 annual periods. Check cash flow reinvestment rate of Universal Ibogaine Inc to assess the company's total reinvestment commitment from operating cash flow.
Universal Ibogaine Inc Cash Flow-to-Debt Ratio by Year (2018–2024)
Universal Ibogaine Inc cash flow-to-debt ratio by year from 2018 to 2024. Year-by-year debt coverage analysis for Universal Ibogaine Inc. For the full cash flow conversion analysis, see Universal Ibogaine Inc (IBO) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.24x | CA$-838.61K | CA$3.52 Million | ▲ +18.6% |
| 2023 | -0.29x | CA$-1.10 Million | CA$3.75 Million | ▲ +84.0% |
| 2022 | -1.82x | CA$-4.33 Million | CA$2.37 Million | ▼ -23.7% |
| 2021 | -1.47x | CA$-3.25 Million | CA$2.20 Million | ▲ +98.6% |
| 2020 | -107.30x | CA$-2.33 Million | CA$21.72K | ▼ -137.7% |
| 2019 | -45.14x | CA$-906.88K | CA$20.09K | ▼ -258.4% |
| 2018 | -12.59x | CA$-320.34K | CA$25.44K | — |